Parse Biosciences

본사

🇺🇸700 Dexter Ave N, Suite 600, Seattle, Washington 98109, US (+2)

산업

연구

직원

200+

설립

2018

회사 유형

Privately Held

순위

#3,169,246

Parse Biosciences is a biotechnology company based in Seattle, founded in 2018. The company focuses on advancing single-cell genomics with innovative solutions that allow researchers to analyze complex biological systems efficiently. Their mission is to support breakthroughs in various fields, including developmental biology, immunotherapy, neurology, diabetes, vascular disease, and cancer. The company specializes in single-cell sequencing technologies, particularly through their Evercode™ Platform. This platform provides an end-to-end solution for library preparation, sequencing, and data analysis, enabling whole transcriptome sequencing and immune profiling without the need for custom instruments. Their offerings include Evercode™ Whole Transcriptome Kits and Immune Profiling Kits, which facilitate scalable workflows and detailed immune repertoire analysis. Parse Biosciences serves researchers and institutions in academic, clinical, and pharmaceutical settings, providing tools that enhance the study of cellular heterogeneity and disease mechanisms.